We are delighted to welcome you to the Autumn edition of European Endocrinology, which includes a wide selection of diabetes content to coincide with the EASD 2017.
This edition includes two articles series for you to enjoy. The first explores the development of DPP-4 inhibitors, including vildagliptin, and how the treatment landscape has evolved since research began 25 years ago. The second series focuses on continuous glucose monitoring, and evaluates how it is been adopted within the UK. Further articles on diabetic macular oedema, diabetes pathophysiology and hyperthyroidism are also included for you to enjoy.
We hope you enjoy these articles, along with the multimedia content you will find accompanying many of the articles in this edition.
Thank you to all of our contributing authors. Our Editor-in-Chief Abd Tahrani would like to welcome all members of the endocrinology community to submit articles to our Spring 2018 edition. Visit our submission system if you have a paper to submit.
Foreword – European Endocrinology, 2017;13(2):47
Welcome to the autumn edition of European Endocrinology. This issue features topical articles that have been selected for their evaluation of current practices, as well as case studies and research that directly affect endocrinologists and other practitioners involved in the care of patients with endocrine disorders. We begin with three articles that emphasise the importance […]
Letter from the Editor-in-Chief
Pathogenesis of Type 2 Diabetes
Type 2 Diabetes
The Vildagliptin Experience – 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin – Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
Continuous Glucose Monitoring
Continuous Glucose Monitoring Adoption in the United Kingdom – An Economic and Policy Perspective
Diabetic Macular Edema
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!